Section: Hepatobiliary Sub-section: Liver Curriculum: Curriculum, page 85

  • Definition:
    • Rare variant of HCC.
    • Defined as well-differentiated polygonal hepatic tumour cells with an eosinophilic granular cytoplasm surrounded by a fibrous lamellar stroma
  • Epidemiology:
    • 1% of HCC.
    • Younger age (20-35 years).
    • Not due to chronic liver disease.
    • Women > men.
  • Presentation:
    • Usually large at time of diagnosis (8-10 cm)
    • Symptoms: palpable mass, abdominal pain, weight loss, malaise, anorexia
  • Imaging:
    • Large solitary hypervascular heterogenous liver mass with central hypodense region due to central necrosis or fibrosis.
    • On MRI, central scar has low attenuation on T2 (as opposed to high attenuation in FNH).
    • Well defined margins and calcification in 68%
  • Pathology:
    • Histology: Deeply eosinophilic, polygonal neoplastic cells surrounded by dense, layered fibrous stroma.
    • Lymph node invasion within hepatic pedicle is frequent (60%).
  • Treatment:
    • Resection. Transplant has little or no place.
    • Lymphadenectomy recommended.
  • Prognosis:
    • Better than HCC. 5-year survival after resection 50-75%
  • Recurrence:
    • High risk within liver, LNs or distant mets
    • Repeat surgery reasonable option due to relatively indolent course of disease and inefficacy of non-surgical treatments
  • Follow-up
    • Close long-term follow-up mandatory. Recurrence and death beyond 5 years common.